Objective
Bacterial endotoxin (lipopolysaccharide, LPS)-mediated sepsis involves dysregulated systemic inflammation, which injures the lung and other organs, often fatally. Vascular endothelial cells act as both targets and mediators of LPS-induced inflammatory responses. Dysfunction of endothelium results in increases of pro-inflammatory cytokine production and permeability leakage. Bone morphogenetic protein (BMP)-binding endothelial regulator (BMPER), an extracellular modulator of BMP signaling, has been identified as a vital component in chronic endothelial inflammatory responses and atherosclerosis. However, it is unclear whether BMPER also regulates inflammatory response in an acute setting such as sepsis. To address this question, we investigated the role of BMPER during LPS-induced acute lung injury.
Approach and results
Mice missing 1 allele of BMPER (BMPER+/− mice used in the place of BMPER−/− mice that die at birth) were used for LPS challenge. LPS-induced pulmonary inflammation and injury was reduced in BMPER+/− mice as shown by several measures, including survival rate, infiltration of inflammatory cells, edema and production of pro-inflammatory cytokines. Mechanistically, we have demonstrated that BMPER is required and sufficient for the activation of nuclear factor of activated T cells (NFAT) c1. This BMPER-induced NFAT activation is coordinated by multiple signaling pathways, including BMP-independent LRP1-ERK activation, calcineurin signaling and LRP1β-mediated nuclear factor-45 (NF45) nuclear export in response to BMPER treatment.
Conclusions
We conclude that BMPER plays a pivotal role in pulmonary inflammatory response, which provides new therapeutic options against sepsis shock. The new signaling pathway initiated by BMPER/LRP1 axis broadens our understanding about BMPER’s role in vascular homeostasis.